Lipid metabolism normally maintains an elegant balance between synthesis and degradation. When the balance is lost, hypertriglyceridemia and hypercholesterolemia may develop. This can cause variety of serious diseases, such as arteriosclerosis, hypertension, obesity, diabetes, functional depression of some organs, etc.
Pancreatic lipase (PL) is a key enzyme for lipid breakdown to absorb fatty acids.
2) PL, one of the exocrine enzymes of pancreatic juice, catalyzes the hydrolysis of emulsified esters of glycerol and long-chain fatty acids. Short-chain fatty acids can be directly absorbed into the blood, while long-chain fatty acids and monoglycerides combine with bile salts to form water soluble micelles.
3) The micelles are absorbed into the mucosal cells of the intestine and the fatty acids and monoglycerides are resynthesized into triglycerides. These triglycerides are formed into small particles known as chylomicrons, which consist of triglycerides, the sterol lipid cholesterol, and apoproteins. These chylomicrons are transported to the muscle and adipose tissue. Dietary triglyceride is usually stored in the adipose tissue. Pharmacological agents that reduce the absorption of dietary triglyceride, thereby reducing the probability of formation of atherosclerotic plaque have been developed such as orlistat and clofibrate. 4) However, the PL lipase-inhibitory activities of natural herbal products have not been studied.
As part of our continuing search for biologically active antiarteriosclerosis agents from natural herbal resources, we measured the PL-inhibitory activity of the rhizome of Alpinia officinarum (AO) and its antihyperlipidemic activity. Extraction of Herbal Medicines Each herbal medicine (1 kg) was extracted twice with water in boiling water for 2 h. These extracts were filtered and evaporated in a rotary vacuum evaporator and then lyophilized with a freeze dryer.
MATERIALS AND METHODS

Materials
Isolation of 3-Methylethergalangin, a PL-Inhibitory Compound, from the Rhizome of AO The rhizome of AO (1 kg) was extracted twice with 5 l of boiling water. After evaporation of the solvent, the extract (125 g) was suspended with water 500 ml. The suspended extracted was extracted stepwise with ethyl ether, ethyl acetate, and butanol. Among these fractions, the most potent PL-inhibitory ethyl acetate fraction (3 g) was applied to silica gel column chromatography and eluted with CHCl 3 : MeOH (10 : 1-2 : 1). Five compounds (AO-1, 2, 3, 4, 5) were isolated. Among them, AO-2 (0.9 g) exhibited the most potent inhibition of PL. Therefore to isolate the active compound homogenously, AO-2 was subjected to preparative HPLC (column: m-Bondapak C18; solvent: 30% MeOH; elution speed 4 ml/min). The isolated compound was identified as 3-methylethergalangin through the instrumental analysis. The pancreatic lipase inhibitory activity of the rhizome of Alpinia officinarum (AO) and its antihyperlipidemic activity were measured. When the water extract of AO was fractionated stepwise with organic solvents, the ethyl acetate fraction exhibited the most potent inhibition. 3-Methylethergalangin was isolated from that fraction as an inhibitor of pancreatic lipase with an IC 50 value of 1.3 mg/ml (triolein as a substrate). AO and its ethyl acetate fraction significantly inhibited the serum TG level in corn oil feeding-induced triglyceridemic mice, and serum triglyceride (TG) and cholesterol in Triton WR-1339-induced hyperlipidemic mice. However, this compound and the AO ethyl acetate fraction did not show hypolipidemic activity in high cholesterol diet-induced hyperlipidemic mice. The results suggest that the hypolipidemic activity of AO and 3-methylethergalangin is due to the inhibition of pancreatic lipase.
3-Methylethergalangin Isolated from Alpinia officinarum Inhibits Pancreatic Lipase
Activity Assay of PL The enzyme activity assay was performed according to the previously reported method. 5) The reaction mixture (3.06 ml) containing 135 mM triolein (or tributyrin) emulsified in gum acasia, 2 mM sodium thioglycolate, and PL (0.6 unit using triacetin as a substrate) and the sample was adjusted to pH 8.8 with 0.1 M NaOH, incubated at 25°C and titrated with 10 mM NaOH to adjust at the pH to 8.8. The inhibitory activity of the sample was calculated from the titrant volume.
Animals Male ICR mice (20-25 g) were purchased from Daehan Experimental Animal (Republic of Korea) and fed a commercial diet (Samyang, Republic of Korea). These animals were kept for at least 7 d prior to the experiments. To evaluate the hypolipidemic effect, three kinds of hyperlipidemic animal models were established.
First, a hyperlipidemic mouse model based on corn oil was established according to the method of Duhault et al. 6 ) Six mice were used per group. Corn oil (1 g/kg) was orally administered 2 h after each sample was administered orally. Two hours after the administration of corn oil, blood samples of mice were drawn by cardiac puncture under ether anesthesia.
Second, a hyperlipidemic mouse model based on Triton WR-1339 was established according to the method of Kusama et al. 7) Triton WR-1339 was injected at the end of the regular 16-h fasting period as a 10% solution in saline at a dose of 200 mg/kg body weight into the tail veins of mice under light ether anesthesia. Six mice were used per group. These mice were anesthetized with ether 18 h after Triton WR-1339 injection and 1-1.5 ml of blood was withdrawn by cardiac puncture. Sera were obtained by centrifugation (1500ϫg, 10 min). Tested samples and orlistat were administered orally once a day for 3 d. The final administration of the samples was performed 1 h before Triton WR-1339 injection.
Third, a hypercholesterolemic mouse model based on high-cholesterol (HC) diets was established according to the method of Niiho et al. 8) Mice were classified into 4 groups (HC control, water extract, orlistat and normal groups). Each group contained 5 mice. The HC control group was fed a normal diet (95.75-96.5%) supplemented with 1% cholesterol, 0.25% cholic acid and 2.5% olive oil (CCO) for 7 consecutive days. The normal group received a solid normal diet (rodent chow: 32% protein, 5% fat, 2% fiber, and 60% nitrogen-free extract) alone. Water extract group was fed on normal diet (95.75-96.5%) supplemented with CCO and orally administered water extract of AO (1 g/kg/d). Water extract group was fed on normal diet (95.75-96.5%) supplemented with CCO and orally administered water extract of orlistat (0.1 g/kg/d). After a 16-h fasting period from the final administration of sample, blood samples were drawn every week from the mice by cardiac puncture under ether anesthesia.
Determination of Total Serum Cholesterol, Triglyceride, and LDL Cholesterol Total cholesterol was measured by the enzyme method of Allain et al. 9) Serum triglycerides were measured by the method designed by Sardesai and Mannig 10) LDL cholesterol was measured by the enzyme method of Mainard and Madec.
11)
Statistical Analysis All the data from the in vivo experiments were expressed as meanϮS.D. and statistical significance was determined using Student's t-test.
RESULTS AND DISCUSSION
In Vitro Inhibitory Effect of AO on PL Activity
Among 200 tested herbal medicines, the water extract of AO potently inhibited PC activity. Therefore the water extract of AO was fractionated stepwise with organic solvents and the enzyme inhibitory effect determined ( Table 1 ). The ethyl acetate fraction exhibited the most potent inhibition. From this fraction, we isolated five compounds (AO-1-5). The most potent inhibitor of PL was AO-2, with an IC 50 value of 1.3 mg/ml (triolein as a substrate). It was confirmed to be 3-methylethergalangin by instrumental analysis.
In Vivo Antihyperlipidemic Activity of AO To evaluate the hypolipidemic effects of AO, we measured its inhibitory activities in Triton WR-1339-induced hyperlipidemic mice (Table 2) . Triglyceride, total cholesterol, and LDL cholesterol levels in serum were increased by treatment with Triton WR-1339. This result was similar to those in a previous report. 12) However, compared with triglyceride, total choles- terol and LDL cholesterol levels in the Triton WR-1339-alone group and those in the AO-and its ethyl acetate fraction-treated groups were significantly decreased. Those in the ethyl acetate fraction-treated group (0.5, 0.1 g/kg, respectively) were decreased to less than those in the control group. We also measured the inhibitory effects in corn oil feedinginduced hyperlipidemic mice (Table 3) . Triglyceride, not cholesterol, levels in serum were increased by treatment with corn oil. In the AO-(1 g/kg) and its ethyl acetate fractiontreated (0.5 g/kg) groups, serum triglyceride levels were significantly decreased to less than those in the control group. The hypolipidemic effects of AO and its ethyl acetate fraction were similar in the mode of inhibition of PL. However, AO water extract did not decrease serum cholesterol levels in hypercholesterolemic mice induced by feeding a high-cholesterol diet (Table 4) . Therefore we isolated the PL inhibitor 3-methylethergalangin from the ethyl acetate fraction of AO and measured its hypolipidemic effect. As shown in Table 5 , 3-methylethergalangin showed potent hypolipidemic activity in Triton WR-1339-induced hyperlipidemic mice. Triglyceride and cholesterol levels were significantly decreased to 81.3% and 81.0% at the 20 mg/kg dose, compared with the Triton WR-1339-alone group, respectively. This compound at 10 and 20 mg/kg doses also exhibited potent antihyperlipidemic activity in corn oil feeding-induced hyperlipidemic mice (Table 6 ). However, 3-methylethergalangin and the AO ethyl acetate fraction did not show hypolipidemic activity in high-cholesterol diet-induced hyperlipidemic mice. We believe that the hypolipidemic activity of AO and 3-methylethergalangin is due to the inhibition of PL, although the effect of its long-term feeding was not investigated. Judging from these results, we propose that PL inhibitors may be effective as hypolipidemic agents. 
